BCTX
Price
$11.00
Change
+$0.29 (+2.71%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
19.49M
PDSB
Price
$1.02
Change
-$0.01 (-0.97%)
Updated
Sep 26 closing price
Capitalization
47.97M
46 days until earnings call
Interact to see
Advertisement

BCTX vs PDSB

Header iconBCTX vs PDSB Comparison
Open Charts BCTX vs PDSBBanner chart's image
Briacell Therapeutics Corp NEW
Price$11.00
Change+$0.29 (+2.71%)
Volume$1K
Capitalization19.49M
PDS Biotechnology
Price$1.02
Change-$0.01 (-0.97%)
Volume$445.6K
Capitalization47.97M
BCTX vs PDSB Comparison Chart in %
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. PDSB commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Buy and PDSB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BCTX: $11.04 vs. PDSB: $1.02)
Brand notoriety: BCTX and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 125% vs. PDSB: 91%
Market capitalization -- BCTX: $19.49M vs. PDSB: $47.97M
BCTX [@Biotechnology] is valued at $19.49M. PDSB’s [@Biotechnology] market capitalization is $47.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whilePDSB’s FA Score has 1 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • PDSB’s FA Score: 1 green, 4 red.
According to our system of comparison, BCTX is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 5 TA indicator(s) are bullish while PDSB’s TA Score has 3 bullish TA indicator(s).

  • BCTX’s TA Score: 5 bullish, 4 bearish.
  • PDSB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BCTX is a better buy in the short-term than PDSB.

Price Growth

BCTX (@Biotechnology) experienced а +20.66% price change this week, while PDSB (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

PDSB is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PDSB($48M) has a higher market cap than BCTX($19.5M). PDSB YTD gains are higher at: -37.423 vs. BCTX (-87.021). BCTX has more cash in the bank: 44.5M vs. PDSB (31.9M). BCTX has less debt than PDSB: BCTX (27K) vs PDSB (18.5M).
BCTXPDSBBCTX / PDSB
Capitalization19.5M48M41%
EBITDAN/A-32.36M-
Gain YTD-87.021-37.423233%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash44.5M31.9M139%
Total Debt27K18.5M0%
FUNDAMENTALS RATINGS
BCTX vs PDSB: Fundamental Ratings
BCTX
PDSB
OUTLOOK RATING
1..100
277
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6592
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDSB's Valuation (30) in the Pharmaceuticals Major industry is significantly better than the same rating for BCTX (96) in the null industry. This means that PDSB’s stock grew significantly faster than BCTX’s over the last 12 months.

PDSB's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as BCTX (100) in the null industry. This means that PDSB’s stock grew similarly to BCTX’s over the last 12 months.

PDSB's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as BCTX (100) in the null industry. This means that PDSB’s stock grew similarly to BCTX’s over the last 12 months.

BCTX's Price Growth Rating (65) in the null industry is in the same range as PDSB (92) in the Pharmaceuticals Major industry. This means that BCTX’s stock grew similarly to PDSB’s over the last 12 months.

BCTX's P/E Growth Rating (1) in the null industry is significantly better than the same rating for PDSB (100) in the Pharmaceuticals Major industry. This means that BCTX’s stock grew significantly faster than PDSB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCTXPDSB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 24 days ago
86%
Declines
ODDS (%)
Bearish Trend 23 days ago
84%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RJF175.713.82
+2.22%
Raymond James Financial
SGHT3.460.03
+0.87%
Sight Sciences
NHI79.750.04
+0.05%
National Health Investors
DCBO27.84-0.51
-1.80%
Docebo
BURU0.12-0.01
-10.14%
Nuburu Inc.

BCTX and

Correlation & Price change

A.I.dvisor tells us that BCTX and KROS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCTX and KROS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
+2.71%
KROS - BCTX
28%
Poorly correlated
+1.46%
PDSB - BCTX
27%
Poorly correlated
-0.97%
LGVN - BCTX
26%
Poorly correlated
+0.44%
GNPX - BCTX
25%
Poorly correlated
-3.48%
PLRX - BCTX
24%
Poorly correlated
+5.90%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with DYN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-0.97%
DYN - PDSB
45%
Loosely correlated
+4.53%
IDYA - PDSB
42%
Loosely correlated
+4.44%
VRDN - PDSB
42%
Loosely correlated
+5.82%
RGNX - PDSB
42%
Loosely correlated
+3.10%
ARCT - PDSB
42%
Loosely correlated
+9.16%
More